Genesis Medtech Corporation
Medtech company operating a vertically integrated platform that sources global medical technologies, develops them via in-house and partner R&D, manufactures in China, and distributes across APAC. Focus areas include minimally invasive surgical devices, neurovascular, cardiovascular and structural heart interventions, with capabilities in regulatory support, market access, clinical training and commercial scale-up.
Industries
Nr. of Employees
Very Large (1000+)
Genesis Medtech Corporation
16 Science Park Drive, Level 4 DNV Technology Centre, Singapore 118227
Patents
Products
Minimally invasive surgical devices
Portfolio including multi-channel single-port access systems, articulating laparoscopic instruments, surgical energy systems, staplers and suture products for general and specialty surgery.
Neurovascular diagnostic and therapy devices
Devices and systems for stroke prevention, diagnosis, endovascular therapy and rehabilitation including access and therapy tools for neurointerventions.
Cardiovascular and peripheral vascular intervention devices
Interventional product lines for cardiovascular disease including intravascular lithotripsy devices and drug-delivery balloon catheters for peripheral vascular treatment.
Structural heart devices (transcatheter valves)
Transcatheter structural heart solutions for valve replacement/repair delivered via minimally invasive approaches.
Minimally invasive surgical devices
Portfolio including multi-channel single-port access systems, articulating laparoscopic instruments, surgical energy systems, staplers and suture products for general and specialty surgery.
Neurovascular diagnostic and therapy devices
Devices and systems for stroke prevention, diagnosis, endovascular therapy and rehabilitation including access and therapy tools for neurointerventions.
Cardiovascular and peripheral vascular intervention devices
Interventional product lines for cardiovascular disease including intravascular lithotripsy devices and drug-delivery balloon catheters for peripheral vascular treatment.
Structural heart devices (transcatheter valves)
Transcatheter structural heart solutions for valve replacement/repair delivered via minimally invasive approaches.
Services
Collaborative development and incubation of medical device technologies with external R&D groups, including accelerator support and technical integration.
Regulatory strategy, prototype testing, ethics submissions and clinical trial management to support product registration in APAC jurisdictions.
Advice and execution for reimbursement strategy, tendering, hospital listing and government engagement to secure adoption and funding.
Direct sales, distributor partnerships and multi-channel marketing to deploy products across hospitals and clinics, supported by training and clinical support.
Localization of production and transfer of manufacturing processes to Chinese production bases to enable scalable device manufacturing.
Collaborative development and incubation of medical device technologies with external R&D groups, including accelerator support and technical integration.
Regulatory strategy, prototype testing, ethics submissions and clinical trial management to support product registration in APAC jurisdictions.
Advice and execution for reimbursement strategy, tendering, hospital listing and government engagement to secure adoption and funding.
Direct sales, distributor partnerships and multi-channel marketing to deploy products across hospitals and clinics, supported by training and clinical support.
Localization of production and transfer of manufacturing processes to Chinese production bases to enable scalable device manufacturing.
Expertise Areas
- Vertically integrated medtech commercialization
- R&D for interventional and surgical devices
- Manufacturing and local scale-up in China
- Regulatory strategy and medical device approvals in APAC
Key Technologies
- Minimally invasive surgical access systems
- Articulating laparoscopic instruments
- Surgical stapling and energy devices
- Absorbable and non-absorbable surgical sutures (PDO, PGA, polypropylene, polyester, polyamide)
News & Updates
Announcement of acquiring a drug-coated balloon technology with a next-generation angioplasty architecture for peripheral vascular disease treatment.
Press announcement regarding a joint venture to expand intravascular lithotripsy and vascular intervention capabilities in China.
Announcement of the official opening and relocation of the company's global HQ in Singapore (Science Park Drive).
Press coverage referencing a significant growth investment raised in a Series B financing round.
Announcement of acquiring a drug-coated balloon technology with a next-generation angioplasty architecture for peripheral vascular disease treatment.
Press announcement regarding a joint venture to expand intravascular lithotripsy and vascular intervention capabilities in China.
Announcement of the official opening and relocation of the company's global HQ in Singapore (Science Park Drive).
Press coverage referencing a significant growth investment raised in a Series B financing round.